PRASUGREL (Ascend Laboratories, LLC)


Welcome to the PulseAid listing for the PRASUGREL drug offered from Ascend Laboratories, LLC. This Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ascend Laboratories, LLC
NON-PROPRIETARY NAME: Prasugrel
SUBSTANCE NAME: PRASUGREL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-10-17
END MARKETING DATE: 0000-00-00


PRASUGREL HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPRASUGREL from Ascend Laboratories, LLC
LABELER NAME: Ascend Laboratories, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/1)
START MARKETING DATE: 2017-10-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67877-604_91138d34-36ca-4854-a514-362cd6001a73
PRODUCT NDC: 67877-604
APPLICATION NUMBER: ANDA205790

Other PRASUGREL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.Prasugrel
Ascend Laboratories, LLCPRASUGREL
Aurobindo Pharma LimitedPrasugrel
Cardinal HealthEffient
Eli Lilly and CompanyEffient
Mylan Pharmaceuticals Inc.Prasugrel
Panacea Biotec Ltd.Prasugrel
Physicians Total Care, Inc.Effient
Prasco LaboratoriesPrasugrel